Placeholder

Global: R&D Outsourcing

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 2381. Categories: , .

Product Description

Myriad pressures have the industry looking toward global R&D outsourcing as a life raft in a sea of change.
A U.K. report by Deloitte and Thomson Reuters surveyed a dozen pharmaceutical companies that spent the most on developing new drugs and discovered that they spent 25% more to bring a product to market in 2011 than in 2010, while the average commercial value of products remained the same as in 2010. The average cost of successfully bringing a product to market increased from $830 million in 2010 to $1.04 billion in 2011. The overall rate of return on R&D dropped from…

Sidebar:
Global Clinical Trials By Country
Tips for Successful R&D Outsourcing
PharmaVOICE: Going Global in 2012

Experts
Glen de Vries
. President, ­Medidata Solutions Worldwide, a global provider of SaaS-based clinical development solutions that enhance the efficiency of customers’ clinical trials. For more information, visit mdsol.com.
Anup Kharode. Director, Global Pharma & Life Sciences, PwC, which provides assurance, tax, and advisory services to proprietary, generic, and specialty drug manufacturers, medical device and ­instrumentation suppliers, biotechnology companies, wholesalers, pharmacy benefit managers, CROs, and industry associations. For more ­information, visit pwc.com.
Nagaraja Srivatsan. Senior VP and Head of the Life Sciences ­Practices, North America, ­Cognizant, a global provider of ­information technology, consulting, and ­business process outsourcing services. For more information, visit cognizant.com.

FEEDBACK